Kenneth R. Deans Jr.
South Carolina
Kenneth R. Deans Jr. is a Contributing Writer for The American Quorum. With 30+ years of leadership across healthcare, technology, and education, he brings an experienced, independent perspective to issues shaping America.
Healthcare
Flu, COVID-19 and RSV Rise Together as CDC Tracks Heavy Winter Hospital Burden and JN.1 Reaches 39%–50% of U.S. Variants
Tech
Apple Wins Temporary Court Stay and Resumes Watch Series 9 and Ultra 2 Sales After U.S. Import Ban
Healthcare
JN.1 Rises to an Estimated 39%–50% of U.S. COVID Variants as WHO Classifies It Separately as a Variant of Interest
Tech
Apple Halts Online U.S. Sales of Watch Series 9 and Ultra 2 as Masimo Patent Dispute Nears Import Ban
Healthcare
Supreme Court Takes Mifepristone Case, Agreeing to Review FDA’s 2016 and 2021 Changes While Current Access Remains in Place
Tech
Epic Wins Google Play Antitrust Trial as Jury Finds Android App Distribution and Billing Practices Unlawfully Restrained Competition
Healthcare
FDA Approves First U.S. CRISPR Therapy and a Second Gene Therapy for Sickle Cell Disease in Patients 12 and Older
Tech
Google Launches Gemini in Ultra, Pro and Nano Versions, Claiming Its Largest AI Model Beats Rivals on 30 of 32 Benchmarks
Healthcare
U.S. Life Expectancy Rebounds 1.1 Years to 77.5 in 2022, but Remains Below 2019 as Suicides Reach Record 49,449
Tech
Tesla Begins Cybertruck Deliveries at $60,990 Base Price, Four Years After Unveiling the Electric Pickup
Healthcare
Cantaloupe Salmonella Outbreak Reaches 99 Cases in 32 States, With 45 Hospitalizations and 2 Deaths
Tech
Sam Altman Set to Return as OpenAI CEO Five Days After Ouster as New Board Replaces Most Directors
Healthcare
FDA Approves First AKT Inhibitor for Biomarker-Selected Advanced Breast Cancer After 50% Reduction in Progression Risk
Tech
OpenAI Board Ousts Sam Altman as CEO, Saying It Lost Confidence After Review of His Communications
Healthcare
FDA Approves Zepbound for Chronic Weight Management After Tirzepatide Delivers About 21% Average Loss at Highest Dose
Tech
OpenAI Launches GPT-4 Turbo With 128K Context, Lower API Prices and Custom GPTs at First DevDay
Healthcare
CMS Finalizes 3.4% Medicare Physician Fee Cut for 2024 While Expanding Primary Care and Behavioral Health Payments
422 stories